Jal S. Jassawalla

Bio: Jal S. Jassawalla is an academic researcher from Baxter International. The author has contributed to research in topics: Blood pump & Transplantation. The author has an hindex of 17, co-authored 32 publications receiving 1546 citations.

Implantable infusion device.

Abstract: An improved implantable infusion device for delivering precisely regulated doses of fluid into the body of a patient. The device utilizes a resilient non-compliant pump bellows (13) that is directly coupled by a gear train (15, 17, 19, 21) to a motor (23). The bellows (13) is biased toward the expanded position and this factor, combined with the mechanical inertia of the gear train (15, 17, 19, 21) substantially eliminates the danger of an overdose of infusate being released into the patient.

Smooth ventricular assist device conduit

Abstract: A smooth-walled non-crimped inflow conduit (160) for an implantable ventricular assist system. The conduit (160) has an internally smooth lumen surface (170) for enhanced washing of the conduit under irregular blood flow conditions. The conduit (160) includes a tubular graft body (168) that may be formed of a knitted fabric sealed with bovine collagen or gelatin, or formed of closed structured PTFE. The conduit may include external ribbing or support (174) to prevent inward collapse under negative pressure conditions and also protect against damage from inadvertent physical contact in the operating room. The external support may be bonded to the exterior or formed integrally with the tubular graft body (168). An outer reinforcement cage (164) may be provided to help prevent gross distortion or damage to the tubular graft body (168). The ends of the tubular graft body are left unsupported and wrapped around opposed lips of conduit coupling structure to minimize blood contacting surfaces at junctions with other conduits or with the heart. The conduit may be provided in an implantable left ventricular assist system also including a pumping device, valved conduits, and a power supply.

Intravenous and intra arterial delivery system

Abstract: An intravenous and intra arterial delivery system is described having a disposable cassette actuated by a pump and control electronics for providing positive but variable delivery rates. The cassette is self-priming and provides protection against the delivery of air by being unable to impel air, and means provide an indication of excessive air in the cassette. The electronics has low power consumption so as to be suitable for battery operation, such as by way of rechargeable batteries. A pressure sensor in the delivery line may be used to sense infiltration. The system further features a provision for predetermining the amount of fluid to be delivered, and a detection system for detecting an empty supply bottle.

Cassette for intravenous delivery system

Abstract: A cassette is described for use in an intravenous delivery system having a pump. The volume of a main chamber defined by the cassette body is varied by a membrane in a wall thereof while unidirectional inlet and outlet valves maintain the direction of fluid flow into and out of the main chamber. A prechamber is positioned above the inlet port in order to accumulate air from the upstream portion of the intravenous delivery system in which the cassette is used.

Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure

Abstract: Background Implantable left ventricular assist devices have benefited patients with end-stage heart failure as a bridge to cardiac transplantation, but their long-term use for the purpose of enhancing survival and the quality of life has not been evaluated. Methods We randomly assigned 129 patients with end-stage heart failure who were ineligible for cardiac transplantation to receive a left ventricular assist device (68 patients) or optimal medical management (61). All patients had symptoms of New York Heart Association class IV heart failure. Results Kaplan–Meier survival analysis showed a reduction of 48 percent in the risk of death from any cause in the group that received left ventricular assist devices as compared with the medical-therapy group (relative risk, 0.52; 95 percent confidence interval, 0.34 to 0.78; P=0.001). The rates of survival at one year were 52 percent in the device group and 25 percent in the medical-therapy group (P=0.002), and the rates at two years were 23 percent and 8 percent...

Analyte Monitoring Device And Methods Of Use

Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.

External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities

Abstract: An infusion system for infusing a liquid into a body includes an external infusion device and a remote commander. The external infusion device includes a housing, a receiver, a processor and an indication device. The receiver is coupled to the housing and for receiving remotely generated commands. The processor is coupled to the housing and the receiver to receive remotely generated commands and to control the external infusion device in accordance with the commands. The indication device indicates when a command has been received and indicates when the command is being utilized to control the external infusion device so that the external infusion device is capable of being concealed from view when being remotely commanded. The remote commander includes a commander housing, a keypad for transmitting commands, and a transmitter for transmitting commands to the receiver of the external infusion device.

System of implantable devices for monitoring and/or affecting body parameters

Abstract: A system for monitoring and/or affecting parameters of a patient's body and more particularly to such a system comprised of a system control unit (SCU) and one or more other devices, preferably battery-powered, implanted in the patient's body, i.e., within the envelope defined by the patient's skin. Each such implanted device is configured to be monitored and/or controlled by the SCU via a wireless communication channel. In accordance with the invention, the SCU comprises a programmable unit capable of (1) transmitting commands to at least some of a plurality of implanted devices and (2) receiving data signal from at least some of those implanted devices. In accordance with a preferred embodiment, the system operates in closed loop fashion whereby the commands transmitted by the SCU are dependent, in part, on the content of the data signals received by the SCU. In accordance with the invention, a preferred SCU is similarly implemented as a device capable of being implanted beneath a patient's skin, preferably having an axial dimension of less than 60 mm and a lateral dimension of less than 6 mm. Wireless communication between the SCU and the implanted devices is preferably implemented via a modulated sound signal, AC magnetic field, RF signal, or electric conduction.

Microprocessor controlled ambulatory medical apparatus with hand held communication device

Abstract: An implantable infusion pump possesses operational functionality that is, at least in part, controlled by software operating in two processor ICs which are configured to perform some different and some duplicate functions. The pump exchanges messages with an external device via telemetry. Each processor controls a different part of the drug infusion mechanism such that both processors must agree on the appropriateness of drug delivery for infusion to occur. Delivery accumulators are incremented and decremented with delivery requests and with deliveries made. When accumulated amounts reach or exceed, quantized deliverable amounts, infusion is made to occur. The accumulators are capable of being incremented by two or more independent types of delivery requests. Operational modes of the infusion device are changed automatically in view of various system errors that are trapped, various system alarm conditions that are detected, and when excess periods of time lapse between pump and external device interactions.